Clinical Usability of Intranasal Glucagon in Treatment of Hypoglycemia

Clinical trial NCT02171130 · COMPLETED

Trial details

NCT number: NCT02171130
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hypoglycemia Diabetes Mellitus Drug-Specific Antibodies

Start date: 2014-05-01
Primary completion: 2015-08-01
Enrollment: 129

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.